DC
VRTX icon

Deere & Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Deere & Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,255
Closed -$2.01M – 1050
2015
Q2 		$2.01M Buy
+16,255
New +$2.05M 0.11% 190

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's VRTX Position: Q3 2015 in Review

Deere & Company sold out of Vertex Pharmaceuticals (VRTX) in Q3 2015, closing a stake of 16,255 shares — an estimated $2.01M sold.

Deere & Company first reported a position in VRTX in Q2 2015 and held it in 1 quarter. The position peaked at $2.01M in Q2 2015. 493 funds tracked by Wall St. Rank hold VRTX as of Q3 2015.

  • Deere & Company reported no remaining Vertex Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Deere & Company sold 16,255 Vertex Pharmaceuticals shares in Q3 2015, an estimated $2.01M.
  • Deere & Company first reported a position in Vertex Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Deere & Company's Vertex Pharmaceuticals position peaked at $2.01M in Q2 2015.
  • 493 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2015.

Based on Deere & Company's 13F filing for Q3 2015, filed 12 Nov 2015.